In addition, DNA-PKcs overexpression has been associated with poor outcomes in patients with NPC undergoing intensity-modulated radiotherapy, suggesting an additional role in predicting response to therapy [157]. Here, PRKDC is linked to nasopharyngeal carcinoma.